5 Spam-Free Article(s) Found
Sort:
Date
Filter:
7d
Article Searches
INmune Bio fails to meet main goal in Alzheimer's treatment study https://seekingalpha.com/news/4463660-inmune-bio-fails-to-meet-main-goal-in-alzheimers-treatment-study?source=feed_sector_healthcare Jun 30, 2025 -
INmune Bio Phase 2 MINDFuL Study Of XPro In Alzheimers Disease Fails; Stock Down In Pre-market https://www.rttnews.com/story.aspx?Id=3549728 Jun 30, 2025 - INmune Bio Inc. (INMB) Monday said that its Phase 2 MINDFuL study of XPro in patients with early Alzheimers Disease (AD) with biomarkers of inflammation did not meet its primary goal. The company's shares were more than 50% down in pre-market.
INmune Bio reverses early gains after stock offering https://seekingalpha.com/news/4463366-inmune-bio-stock-falls-stock-offering?source=feed_sector_healthcare Jun 27, 2025 -
Vor Bio surges after private placement, licensing deal https://seekingalpha.com/news/4462943-vor-bio-stock-surges-private-placement?source=feed_sector_healthcare Jun 26, 2025 -
Vor Bio announces $175M private placement https://seekingalpha.com/news/4462458-vor-bio-announces-175m-private-placement?source=feed_sector_healthcare Jun 25, 2025 -

Pages: 1

Page 1